338 related articles for article (PubMed ID: 19408409)
21. Striving to improve outcomes in oncology: unmet expectations in a complex disease.
Bates SE
Clin Cancer Res; 2010 Dec; 16(24):5950. PubMed ID: 21169246
[No Abstract] [Full Text] [Related]
22. Recent developments in cancer therapy and why we need a human cancer genome project.
Becker GJ
J Am Coll Radiol; 2005 Nov; 2(11):887-8. PubMed ID: 17411961
[No Abstract] [Full Text] [Related]
23. [Desperately seeking targets].
Jordan B
Med Sci (Paris); 2015 Feb; 31(2):214-7. PubMed ID: 25744270
[TBL] [Abstract][Full Text] [Related]
24. What's new in surgical oncology.
Norton JA
J Am Coll Surg; 1996 Feb; 182(2):122-9. PubMed ID: 8564043
[No Abstract] [Full Text] [Related]
25. Searching for the answer to cancer: new perspective may help to resolve an ageless conundrum.
Watson RA
Urol Oncol; 2013 Aug; 31(6):721-6. PubMed ID: 23769267
[No Abstract] [Full Text] [Related]
26. Advances in drug development: off-label drug utilization in oncology.
de Souza JA
Clin Adv Hematol Oncol; 2011 Jun; 9(6):473-5. PubMed ID: 21841748
[No Abstract] [Full Text] [Related]
27. The cancer genome and diagnostic blood tests.
Lance P
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2017-8. PubMed ID: 17119024
[No Abstract] [Full Text] [Related]
28. Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy?
Markman M
J Clin Oncol; 2007 Aug; 25(23):3554; author reply 3557-8. PubMed ID: 17687167
[No Abstract] [Full Text] [Related]
29. The best medicine? Prevention. It's increasingly clear that a healthful lifestyle matters.
Hobson K
US News World Rep; 2008 Nov 3-10; 145(10):53. PubMed ID: 18998443
[No Abstract] [Full Text] [Related]
30. Type of oncology specialist and treatment-related outcomes in ovarian cancer.
Hoffman MA; Iqbal U
J Clin Oncol; 2007 Aug; 25(23):3553; author reply 3557-8. PubMed ID: 17687165
[No Abstract] [Full Text] [Related]
31. [Do Norwegian cancer patients receive the care they deserve?].
Wilking N; Jönsson B; Svedman C
Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2828-9. PubMed ID: 17086228
[No Abstract] [Full Text] [Related]
32. ESMO 2014: new trends in precision medicine.
Morere JF; Innominato P
Target Oncol; 2014 Dec; 9(4):293-4. PubMed ID: 25503266
[No Abstract] [Full Text] [Related]
33. [Current trends in clinical chemotherapy of tumors].
Garan AM
Vopr Onkol; 1983; 29(1):93-8. PubMed ID: 6823764
[No Abstract] [Full Text] [Related]
34. Cancer chemotherapy in the older cancer patient.
Carreca I; Balducci L
Urol Oncol; 2009; 27(6):633-42. PubMed ID: 19879474
[TBL] [Abstract][Full Text] [Related]
35. [Evolution of treatments, what upheavals?].
Jouet JP
Soins; 2008 Mar; (723):61. PubMed ID: 18380319
[No Abstract] [Full Text] [Related]
36. Ovarian cancer and the battle of the specialists.
McGuire WP
J Clin Oncol; 2007 Aug; 25(23):3554-5; author reply 3557-8. PubMed ID: 17687166
[No Abstract] [Full Text] [Related]
37. Unlocking the secrets of cancer.
Healy B
US News World Rep; 2008 Nov 3-10; 145(10):46-7. PubMed ID: 18998441
[No Abstract] [Full Text] [Related]
38. Special report: pharmacogenomics of cancer-candidate genes.
Technol Eval Cent Assess Program Exec Summ; 2007 Nov; 22(5):1-3. PubMed ID: 18080403
[No Abstract] [Full Text] [Related]
39. Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA.
Scholler N
IDrugs; 2009 Apr; 12(4):207-10. PubMed ID: 19350459
[No Abstract] [Full Text] [Related]
40. [New perspectives in cancer treatment].
Brugarolas A; Giráldez J
Rev Med Univ Navarra; 1998; 42(3):127-33. PubMed ID: 10420935
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
